JWH-018 binds to the two the CB1 and CB2 receptors. The effects of JWH-018 are mostly attributable for the binding and activation of CB1 receptors. In practice, the compound suppresses the release of neurotransmitters in the central nervous procedure, which clarifies the large number of consequences